Interview: Meet Don Millard of Red Bag Solutions in Vinings

Today we’d like to introduce you to Don Millard.

Red Bag Solutions’ Steam Sterilization and Maceration technology was invented by a retired US Navy dentist in response to the growing need for effective and safe technology to process medical waste in the wake of EPA rulings that effectively eliminated the use of incinerators by hospitals and the ineffectiveness of autoclaves to process this waste.

For more than a quarter century Red Bag Solutions has provided innovative technology, equipment and services for on-site processing of medical and biohazardous waste. The company has manufactured and sold its patented Steam Sterilization and Maceration (SSM) systems throughout the world. Red Bag Solutions’ patented Steam Sterilization and Maceration (SSM) technology is the basis of our unique biohazardous waste processing system. It is designed for safe, efficient and cost-effective processing of:

  • Biological agents and infectious materials,
  • Needles, syringes and disposable surgical instruments,
  • Blood products and body fluids,
  • Pathogens: bacterial, viral, fungi or proteinaceous infectious agents,
  • Contaminated plastics,
  • Confidential media and proprietary materials,

SSM processed waste is sterilized, safe and no longer recognizable as medical waste. Therefore, it can be repurposed, recycled or disposed of as ordinary municipal trash.

Unlike medical waste incinerators and autoclaves, SSM processing is free of objectionable odors and does not release any negative air emissions. It is more environmentally friendly and less costly than any other on-site medical waste management alternative.

Red Bag Solutions’ customers include hospitals and healthcare facilities, pharmaceutical and biotechnology companies, and diagnostic laboratories and research facilities. We realize that every facility’s requirements are unique, and we work hard to make sure that those specific requirements are met. The SSM technology can be adapted to suit a variety of specialized applications such as processing 100% liquid waste streams, utilizing ozone as a sterilant and supporting BSL-3 laboratories.

Overall, has it been relatively smooth? If not, what were some of the struggles along the way?
The most prevalent technology for treating medical waste is to haul it to a central facility where it is treated and subsequently disposed of in a landfill. This model aligns with everyone’s familiarity with “taking out the garbage” and a mindset of out of sight, out of mind. Convincing healthcare facilities that on-site treatment, which avoids the inherent risks and increased generation of greenhouse gases associated with transport, is a superior option has been a struggle. Biotechnology companies and diagnostic laboratories, with great motivation to protect confidential patient information and trade secrets, were early adopters of SSM technology. Government green initiatives were an important influence in the adoption of SSM technology in government facilities and VA Hospitals. Today there is a growing interest from healthcare facilities in sustainable green technologies and this is driving increased interest and opportunities for Red Bag Solutions SSM technology.

Alright – so let’s talk business. Tell us about Red Bag Solutions – what should we know?
We are proud of the fact that we can take medical waste and transform it into a material that is unrecognizable and is safe for disposal in an ordinary landfill. Because the end product has been sterilized it may also be recycled or repurposed in waste to energy operations. This is a better outcome for our customers, our communities and our environment.

Any shoutouts? Who else deserves credit in this story – who has played a meaningful role?
We owe a great deal of thanks to our original investors who have stood with us over the years and provided invaluable support and encouragement. We also received tremendous support and encouragement from the team at Fulcrum Equity Partners in Atlanta. Fulcrum CEO Jeff Muir has been a tireless advisor and advocate for us.

Contact Info:


This article originally appeared on